rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Roxanne Lagano

Executive Vice President

Company insider

Files Form 4 as: Executive Vice President, Zoetis.

Every Form 4 they filed

In numbers

Trades disclosed
298
Buys
1
Sells
42
Bought
$52K
Sold
$28.8M
Companies
1
Companies where not an officer
0
First trade
31 Jan 2013
Last trade
9 Oct 2026
Last filed
13 Oct 2026

Companies traded

Where they are an officer
ZTS ZoetisOfficer · Pharmaceuticals · last 9 Oct 20261 buy · 42 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
9 Oct 2026filed 13 Oct 2026ZTS Zoetisoption or derivative · PharmaceuticalsSEC FORM 4 Code A$9,625367.788 at $26.17filing
10 Jul 2026filed 14 Jul 2026ZTS Zoetisoption or derivative · PharmaceuticalsSEC FORM 4 Code A$8,250314.645 at $26.22filing
10 Jul 2026filed 14 Jul 2026ZTS Zoetisoption or derivative · PharmaceuticalsSEC FORM 4 Code A$8,250314.65 at $26.22filing
10 Apr 2026filed 13 Apr 2026ZTS Zoetisoption or derivative · PharmaceuticalsSEC FORM 4 Code A$22K550.644 at $39.64filing
10 Apr 2026filed 13 Apr 2026ZTS Zoetisoption or derivative · PharmaceuticalsSEC FORM 4 Code A$22K550.64 at $39.64filing
27 Mar 2026filed 31 Mar 2026ZTS Zoetisoption or derivative · PharmaceuticalsSEC FORM 4 Code A$48K1,266.441 at $38.20filing
27 Mar 2026filed 31 Mar 2026ZTS Zoetisoption or derivative · PharmaceuticalsSEC FORM 4 Code A$48K1,266.44 at $38.20filing
19 Feb 2026filed 23 Feb 2026ZTS ZoetisPharmaceuticalsSEC FORM 4 Code M—750filing
19 Feb 2026filed 23 Feb 2026ZTS ZoetisPharmaceuticalsSEC FORM 4 Code F$33K258 at $127.28filing
19 Feb 2026filed 23 Feb 2026ZTS Zoetisoption or derivative · PharmaceuticalsSEC FORM 4 Code M—750.426filing
19 Feb 2026filed 23 Feb 2026ZTS Zoetisoption or derivative · PharmaceuticalsSEC FORM 4 Code M—750.43filing
19 Feb 2026filed 23 Feb 2026ZTS ZoetisPharmaceuticalsSEC FORM 4 Code M—750filing
19 Feb 2026filed 23 Feb 2026ZTS ZoetisPharmaceuticalsSEC FORM 4 Code F$33K258 at $127.28filing
18 Feb 2026filed 19 Feb 2026ZTS Zoetisoption or derivative · PharmaceuticalsSEC FORM 4 Code A—3,664 at $0.00filing
18 Feb 2026filed 19 Feb 2026ZTS Zoetisoption or derivative · PharmaceuticalsSEC FORM 4 Code A—14,499 at $0.00filing
18 Feb 2026filed 19 Feb 2026ZTS Zoetisoption or derivative · PharmaceuticalsSEC FORM 4 Code A—3,664 at $0.00filing
18 Feb 2026filed 19 Feb 2026ZTS Zoetisoption or derivative · PharmaceuticalsSEC FORM 4 Code A—14,499 at $0.00filing
8 Feb 2026filed 10 Feb 2026ZTS ZoetisPharmaceuticalsSEC FORM 4 Code M—605filing
8 Feb 2026filed 10 Feb 2026ZTS Zoetisoption or derivative · PharmaceuticalsSEC FORM 4 Code M—605.73filing
8 Feb 2026filed 10 Feb 2026ZTS ZoetisPharmaceuticalsSEC FORM 4 Code F$28K221 at $127.42filing

News

ZTS - Zoetis Inc Class A AnalysisZTS · morningstar.com · 12 Oct 2026

0 headlines in the last 90 days name Roxanne Lagano; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care43

Buys in green, sells in red, by the company’s sector.

Related people

Abhay U. NayakExecutive Vice President · Executive Vice President at Zoetis, filing Form 4 there in the last year
Rimma DriscollExecutive Vice President · Executive Vice President at Zoetis, filing Form 4 there in the last year
Kristin C. PeckChief Executive Officer · Chief Executive Officer at Zoetis, filing Form 4 there in the last year
Astorga Jeannette FerranExecutive Vice President · Executive Vice President at Zoetis, filing Form 4 there in the last year
Julie FullerExecutive Vice President · Executive Vice President at Zoetis, filing Form 4 there in the last year
Gilbert Ray Cisneros, Jr.Representative, CA-31 · Also traded ZTS in the last 90 days
Donald J. TrumpPresident · Also traded ZTS in the last 90 days